375
Participants
Start Date
April 29, 2024
Primary Completion Date
March 31, 2040
Study Completion Date
March 31, 2040
No Intervention
As this is a non-interventional rollover, long-term safety follow-up study, no intervention will be administered.
RECRUITING
University of Maryland Medical Center, Baltimore
RECRUITING
Levine Cancer Institute, Charlotte
RECRUITING
University of Cincinnati Medical Center, Cincinnati
NOT_YET_RECRUITING
Corewell Health, Grand Rapids
NOT_YET_RECRUITING
Banner MD Anderson Cancer Center, Gilbert
NOT_YET_RECRUITING
University of Southern California - Norris Comprehensive Cancer Center, Los Angeles
RECRUITING
Swedish Cancer Institute, Seattle
Lead Sponsor
Century Therapeutics, Inc.
INDUSTRY